A Multi-Institution Study of TGFss; imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination with Gemcitabine and Docetaxel in Patients with Relapsed or Refractory Pediatric Bone and Soft Tissue Sarcomas
Clinical Trial Grant
Administered By
Pediatrics, Hematology-Oncology
Awarded By
H. Lee Moffitt Cancer Center & Research Institute
Start Date
February 5, 2024
End Date
October 31, 2028
Administered By
Pediatrics, Hematology-Oncology
Awarded By
H. Lee Moffitt Cancer Center & Research Institute
Start Date
February 5, 2024
End Date
October 31, 2028